# DESCRIPTION

## TECHNICAL FIELD

- define technical field

## BACKGROUND

- limitations of bioluminescence imaging

## SUMMARY

- outline method of identifying non-diabetic pancreatic Î²-cells

## DESCRIPTION OF THE DISCLOSURE

- define terms and conventions
- describe scope and limitations of disclosure

### DEFINITIONS

- define terms of art and notation
- define terms related to diabetes and beta cells
- define terms related to coelenterazine and bioluminescence
- define terms related to pharmaceutical carriers and formulations

### Description

- describe need for beta cell mass imaging agents
- describe limitations of current diagnostic techniques
- describe use of coelenterazine for imaging beta cell mass
- describe in vitro and in vivo experiments
- describe potential applications of coelenterazine-based imaging

### EXAMPLES

- describe in vitro and in vivo imaging protocols

